Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution
- 7 September 2016
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 31 (5) , 2233-2241
Abstract
Background Pancreaticoduodenectomy remains as the only treatment that offers a chance for cure in patients with pancreatic ductal adenocarcinoma (PDAC) of the head of the pancreas. In recent years, laparoscopic pancreaticoduodenectomy (LPD) has been introduced as a feasible alternative to open pancreaticoduodenectomy (OPD) when performed by experienced surgeons. This study reviews and compares perioperative results and long-term survival of patients undergoing LPD versus OPD at a single institution over a 20-year time period. Methods From 1995 to 2014, 612 patients underwent PD and 251 patients were found to have PDAC. These latter patients were reviewed and divided into two groups: OPD (n = 193) and LPD (n = 58). LPD was introduced in November 2008 and performed simultaneous to OPD within the remaining time period. Ninety-day perioperative outcomes and long-term survival were analyzed. Results Patient demographics were well matched. Operative time was significantly longer with LPD, but blood loss and transfusion rate were lower. Postoperative complications, intensive care unit stay, and overall hospital stay was similar. OPD was associated with larger tumor size; LPD was associated with greater lymph node harvest and lower lymph node ratio. LPD was performed by hand-assist method in 3 (5.2 %) patients and converted to open in 14 (24.1 %). Neoadjuvant therapy was performed in 17 (8.8 %) patients for OPD and 4 (6.9 %) for LPD. The estimated median survival was 20.3 months for OPD and 18.5 months for LPD. Long-term survival was similar for 1-, 2-, 3-, 4-, and 5-year survival for OPD (68, 40, 24, 17 and 15 %) and for LPD (67, 43, 43, 38 and 32 %), respectively. Conclusion LPD provides similar short-term outcomes and long-term survival to OPD in the treatment of PDAC.Keywords
Funding Information
- Mayo Clinic
This publication has 27 references indexed in Scilit:
- Effects of Perioperative Red Blood Cell Transfusion on Disease Recurrence and Survival After Pancreaticoduodenectomy for Ductal AdenocarcinomaAnnals of Surgical Oncology, 2011
- Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the PancreasPancreas, 2011
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic CancerJournal of Gastrointestinal Surgery, 2009
- Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)Surgery, 2007
- Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based AnalysisAnnals of Surgical Oncology, 2007
- Laparoscopic Pancreaticoduodenectomy: Technique and OutcomesJournal of the American College of Surgeons, 2007
- Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definitionSurgery, 2007
- Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancerSurgery, 2007
- Postoperative pancreatic fistula: An international study group (ISGPF) definitionSurgery, 2005